Hugel Inc
KOSDAQ:145020
Hugel Inc
Effect of Foreign Exchange Rates
Hugel Inc
Effect of Foreign Exchange Rates Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Effect of Foreign Exchange Rates | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
H
|
Hugel Inc
KOSDAQ:145020
|
Effect of Foreign Exchange Rates
₩4.8B
|
CAGR 3-Years
40%
|
CAGR 5-Years
54%
|
CAGR 10-Years
N/A
|
|
|
Celltrion Inc
KRX:068270
|
Effect of Foreign Exchange Rates
₩52.4B
|
CAGR 3-Years
43%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
59%
|
|
|
SK Bioscience Co Ltd
KRX:302440
|
Effect of Foreign Exchange Rates
₩7.7B
|
CAGR 3-Years
601%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
N
|
NatureCell Co Ltd
KOSDAQ:007390
|
Effect of Foreign Exchange Rates
₩438.5m
|
CAGR 3-Years
70%
|
CAGR 5-Years
33%
|
CAGR 10-Years
38%
|
|
|
P
|
PharmaResearch Co Ltd
KOSDAQ:214450
|
Effect of Foreign Exchange Rates
₩1.1B
|
CAGR 3-Years
55%
|
CAGR 5-Years
59%
|
CAGR 10-Years
N/A
|
|
|
Alteogen Inc
KOSDAQ:196170
|
Effect of Foreign Exchange Rates
₩262.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Hugel Inc
Glance View
In the bustling landscape of the global biopharmaceutical market, Hugel Inc. stands out as a formidable player rooted in the dynamic world of aesthetics and medical treatments. Established in South Korea, Hugel Inc. embarked on its journey with a focus on producing botulinum toxin products, a niche that has rapidly expanded due to a surge in demand for non-surgical cosmetic procedures. The company navigated early challenges with innovative prowess, crafting a strong reputation for high-quality products that cater to a global clientele. The ethos of innovation and safety permeates its operations, enabling Hugel to diversify its portfolio and steadily gain traction in international markets, including significant footprints in Asia, Europe, and Latin America. Through a network of strategic partnerships and a robust distribution channel, Hugel not only pioneered advancements in cosmetic treatments but also cemented its status as a key contributor to the evolving aesthetics industry. The company's revenue model hinges upon the development, production, and distribution of its botulinum toxin and hyaluronic acid-based products. By focusing on research and development, Hugel enhances its capacity to innovate, delivering cutting-edge solutions that meet the rising demands of beauty-conscious consumers. Its business strategy also extends to therapeutics, exploring potential applications of its core products to address various medical conditions. Hugel's financial growth is propelled by the continuous expansion into new geographical territories and the gradual introduction of new, clinically-researched products. As the company continues to navigate the intricate regulatory landscapes of the pharmaceutical industry, it maintains an unwavering commitment to quality, ensuring that each product meets rigorous safety standards while catering to the evolving desires of its diverse customer base worldwide.
See Also
What is Hugel Inc's Effect of Foreign Exchange Rates?
Effect of Foreign Exchange Rates
4.8B
KRW
Based on the financial report for Dec 31, 2024, Hugel Inc's Effect of Foreign Exchange Rates amounts to 4.8B KRW.
What is Hugel Inc's Effect of Foreign Exchange Rates growth rate?
Effect of Foreign Exchange Rates CAGR 5Y
54%
Over the last year, the Effect of Foreign Exchange Rates growth was 1 109%. The average annual Effect of Foreign Exchange Rates growth rates for Hugel Inc have been 40% over the past three years , 54% over the past five years .
You don't have any saved screeners yet